Neurostimulation to Improve NOWS Outcomes

NCT05129020 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Neonatal Opioid Withdrawal Syndrome
Neonatal Abstinence Syndrome

Interventions

DEVICE: Sparrow Fledging Therapy System
DEVICE: Sham Sparrow Fledging Therapy System

Sponsor

Spark Biomedical, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]